-
Posted by
Two Blokes Jul 25 -
Filed in
Stock
-
1 view
Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF), a Canadian clinical-stage drug development company, said it has closed the second tranche of a non-brokered private placement, raising total gross proceeds of C$761,000 from the sale of subscription receipts. The financing, first announced on May 27 and updated on June 30, includes C$90,000 from company insiders.
